Cigna Corp. (CI) Tops Q4 EPS by 25c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- Moderna stock rises on latest cancer vaccine data publication
CIGNA (CI) PT Raised to $360 at Goldman Sachs
February 5, 2024 7:22 AM ESTGoldman Sachs analyst Nathan Rich raised the price target on CIGNA (NYSE: CI) to $360.00 (from $352.00) while maintaining a Neutral rating.
The analyst comments "CI outperformed (+5.4% on 2/2 vs S&P +1.1%) after reporting 4Q23 EPS 3%/4% above GS/consensus (FactSet), raising its 2024 EPS guidance by ~1% to >$28.25 from >$28.00, and reemphasizing its prioritization of share repurchases as... More



